<html>
<head>PUBMED IDs for CRYL1</head>
<body bgcolor='#C5F0F2'><h1>CRYL1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12527201/'>Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney and downregulated in 58% of liver cancer tissues from 60 Chinese patients, and four new homologs from other mammalians.</a> January 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16075462/'>Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11.</a> August 3  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17321332/'>Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.</a> February 27  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19101659/'>A new large deletion in the DFNB1 locus causes nonsyndromic hearing loss.</a> November 3  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19927314/'>Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis.</a> March 27  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/24958192/'>Genome-wide association interaction analysis for Alzheimer's disease.</a> October 20  2014<br></body></html>
